Shares of Aptose Biosciences Inc. (TSE:APS – Get Free Report) (NASDAQ:APTO) reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as C$5.15 and last traded at C$5.15, with a volume of 2788 shares changing hands. The stock had previously closed at C$0.17.
Aptose Biosciences Stock Up 3,021.2 %
The firm has a 50 day moving average price of C$0.29 and a two-hundred day moving average price of C$0.42. The company has a current ratio of 1.05, a quick ratio of 5.41 and a debt-to-equity ratio of -117.37. The firm has a market capitalization of C$221.75 million, a price-to-earnings ratio of -1.03 and a beta of 1.36.
About Aptose Biosciences
Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.
See Also
- Five stocks we like better than Aptose Biosciences
- What is a SEC Filing?
- Buffett’s on the Sidelines – Should You Follow?
- Technology Stocks Explained: Here’s What to Know About Tech
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- 3 Warren Buffett Stocks to Buy Now
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Aptose Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptose Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
